GABA-Pro®

GABA-Pro®

Fast Acting Calm Effect

90 Chewable Tablets ( SKU: 9283, NPN: 80052082 )

Benefits

  • Improves calmness and relaxation with daily stress, reduces the negative effects of caffeine consumption, and complements other anti-stress supplements
  • Fast acting, effects can be felt in as little as five minutes and can last from four to six hours
  • GABA-Pro uses Pharma GABATM, the natural form of GABA which is superior to the synthetic. It is naturally manufactured via a fermentation process that utilizes Lactobacillus hilgardii, the bacterium used to ferment vegetables in the preparing the traditional Korean dish kimchi.
  • Gentle and non-addictive with virtually no side effects
  • Delicious tropical fruit flavoured chewable
  • Suitable for vegetarians/vegans

Feature Summary

Gamma amino butyric acid (GABA) is one of the major inhibitory neurotransmitters in the central nervous system, balancing the excitatory effects of glutamate on neuronal activity. The inhibitory effects of GABA are generally considered to lessen anxiety, relax muscle tension, and have sedative-like effects.1 In addition, conditions such as anxiety, depression, insomnia, and epilepsy have all been associated with low GABA concentration or activity.2,3 GABA has also been shown to cause a significant increase in alpha brain waves compared to control, indicative of a more relaxed state, as well as better concentration. In a clinical trial involving patients with a fear of heights, GABA-Pro was found to increase salivary levels of sIgA while crossing a suspension bridge, as compared to the control group whose salivary IgA levels dropped 35%.4 This is indicative of the stress reducing effect of GABA-Pro.5,6

Increasing GABA activity is also a therapeutic target for many medications used in the treatment of insomnia, often by targeting GABA receptors. This has the effect of decreasing waking, shorten sleep latency, and increasing slow-wave sleep.7,8

Medicinal Ingredients

Serving Size: 2 Chewable Tablets
Servings per Container: 45

Each Chewable Tablet Contains:
Gamma-Aminobutyric Acid (GABA)...................................................100 mg
(from 129 mg Pharma GABATM 80 Complex)

Non-Medicinal Ingredients

Xylitol, stearic acid, hydroxypropylcellulose, silica, natural tropical fruit flavour (banana, pomegranate, pineapple, mango, passionfruit, orange, tangerine, mandarin), citric acid, vegetable grade magnesium stearate (lubricant).

Allergens:

Contains no artificial colours, preservatives, or sweeteners; no dairy, starch, wheat, gluten, soy, egg, fish, shellfish, animal products, salt, tree nuts, or GMOs. Suitable for vegetarians/vegans. Sealed for your protection. Do not use if seal is broken. For freshness, store in a cool, dry place.

Contraindications

Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner if symptoms persist or worsen. Consumption with alcohol, other medications or health products with sedative properties is not recommended. Keep out of reach of children

Drug Interactions

No known drug interactions have been documented; however a theoretical concern exists for interaction with CNS depressants.

  1. Gajcy K, Lochyñski S, Librowski T. A role of GABA analogues in the treatment of neurological diseases. Curr Med Chem. 2010;17(22):2338-47.
  2. Kendell SF, Krystal JH, Sanacora G. GABA and glutamate systems as therapeutic targets in depression and mood disorders. Expert Opin Ther Targets. 2005:9:153-168.
  3. Nemeroff CB. The role of GABA in the pathophysiology and treatment of anxiety disorders. Psychopharmacol Bull. 2003:37:133-146.
  4. Abdou AM, Higashiguchi S, Horie K, et al. Relaxation and immunity enhancement effects of gamma aminobutyric acid (GABA) administration in humans. Biofactors 2006;26:201-208.
  5. Yoto A, Murao S, Motoki M, et al. Oral intake of -aminobutyric acid affects mood and activities of central nervous system during stressed condition induced by mental tasks. Amino Acids. 2012 Sep;43(3):1331-7. doi: 10.1007/s00726-011-1206-6.
  6. Yang Y, Koh D, Ng V, et al. Self perceived work related stress and the relation with salivary IgA and lysozyme among emergency department nurses. Occup Environ Med. 2002;59(12):836-841.
  7. Walsh JK, Salkeld L, Knowles LJ, et al. Treatment of elderly primary insomnia patients with EVT 201 improves sleep initiation, sleep maintenance, and daytime sleepiness. Sleep Med. 2010 Jan;11(1):23-30. doi: 10.1016/j.sleep.2009.07.012.
  8. Lundahl J, Staner L, Staner C, et al. Short-term treatment with gaboxadol improves sleep maintenance and enhances slow wave sleep in adult patients with primary insomnia. Psychopharmacology (Berl). 2007 Nov;195(1):139-46.